House Dust Mite, Dermatophagoides Farinae (Page 3 of 3)

REFERENCES

  1. Turkeltaub, P.C. The allergy unit-clinical relevance: issues in allergen standardization. In: R.F. Lockey, S.C. Bukantz, eds. Allergen Immunotherapy. New York, NY: Marcel Dekker, Inc., 171-190, 1991.
  2. Wharton, G.W. House dust mites. J. Med. Entomol., 12:577, 1976.
  3. Voorhost, R., F.Th.M. Spieksma and H. Varekamp. House dust atopy and the house mite. Leiden, Stafleus Scientific Publishing Co., 1969.
  4. Baer, H. Allergy to house dust mites. Immuno. Allergy Practice, 5:356, 1983.
  5. Lang, J.D. and S. Mulla. Distribution and abundance of house dust mites, Dermatophagoides (spp.) in different zones of Southern California. Environmental Entomology, 6:213, 1977.
  6. Pauli, G., J.C. Bessot, R. Thierry, and A. Lamensans. Correlation between skin tests, inhalation tests and specific IgE in a study of 120 subjects allergic to house dust and D. pteronyssinus. Clin. Allergy, 7:337, 1977.
  7. Murray, A.B., A.C. Fergusson and B.J. Morrison. Diagnosis of house dust mite allergy in asthmatic children. What constitutes a positive history? J. Allergy Clin. Immunol., 71:21, 1983.
  8. Warner, J.O., J.F. Price, J.F. Soothill and E.N. Hey. Controlled trial of hyposensitization to D. pteronyssinus in children with asthma. Lancet, 2:912, 1978.
  9. Smith, A.P., Hyposensitization with D. pteronyssinus antigen. Trial in asthma induced by house dust. Br. Med. J., 4:204, 1971.
  10. Middleton, E. Jr., C.E. Reed, F.E. Ellis, N.F. Adkinson Jr., J.W. Yunginger, W.W. Busse, Allergy Principles and Practice, 5th Ed., Vol II, 394-404, 1050., Mosby, St. Louis, 1998.
  11. Reid, M.J., R.F. Lockey, P.C. Turkeltaub, T.A.E. Platts-Mills. Survey of fatalities from skin testing and immunotherapy 1985-1989. J. Allergy Clin. Immunol., 92:6, 1993.

0702-05_Std D farinae_5mL

0704-10_Std D pteronyssinus_10mL0702-05_Std D farinae_5mL0704-10_Std D pteronyssinus_10mL
HOUSE DUST MITE, DERMATOPHAGOIDES FARINAE house dust mite, dermatophagoides farinae injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49643-702
Route of Administration CUTANEOUS, INTRADERMAL, SUBCUTANEOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DERMATOPHAGOIDES FARINAE (DERMATOPHAGOIDES FARINAE) DERMATOPHAGOIDES FARINAE 10000 [AU] in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE 0.0025 g in 1 mL
SODIUM BICARBONATE 0.00125 g in 1 mL
GLYCERIN 0.53 g in 1 mL
PHENOL 0.004 g in 1 mL
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:49643-702-05 5 mL in 1 VIAL, MULTI-DOSE None
2 NDC:49643-702-10 10 mL in 1 VIAL, MULTI-DOSE None
3 NDC:49643-702-50 50 mL in 1 VIAL, MULTI-DOSE None
4 NDC:49643-702-30 30 mL in 1 VIAL, MULTI-DOSE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA102212 12/24/1986
HOUSE DUST MITE, DERMATOPHAGOIDES PTERONYSSINUS house dust mite, dermatophagoides pteronyssinus injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:49643-704
Route of Administration CUTANEOUS, INTRADERMAL, SUBCUTANEOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
DERMATOPHAGOIDES PTERONYSSINUS (DERMATOPHAGOIDES PTERONYSSINUS) DERMATOPHAGOIDES PTERONYSSINUS 10000 [AU] in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM CHLORIDE 0.0025 g in 1 mL
SODIUM BICARBONATE 0.00125 g in 1 mL
GLYCERIN 0.53 g in 1 mL
PHENOL 0.004 g in 1 mL
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:49643-704-05 5 mL in 1 VIAL, MULTI-DOSE None
2 NDC:49643-704-10 10 mL in 1 VIAL, MULTI-DOSE None
3 NDC:49643-704-50 50 mL in 1 VIAL, MULTI-DOSE None
4 NDC:49643-704-30 30 mL in 1 VIAL, MULTI-DOSE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA102213 12/24/1986
Labeler — Allermed Laboratories, Inc. (073364531)
Establishment
Name Address ID/FEI Operations
Allermed Laboratories, Inc. 073364531 manufacture (49643-702), manufacture (49643-704)

Revised: 09/2019 Allermed Laboratories, Inc.

Page 3 of 3 1 2 3

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2021. All Rights Reserved.